These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28842748)

  • 1. PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
    Koh YW; Han JH; Yoon DH; Suh C; Huh J
    Ann Hematol; 2017 Nov; 96(11):1883-1890. PubMed ID: 28842748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma.
    Xue S; Hu M; Li P; Ma J; Xie L; Teng F; Zhu Y; Fan B; Mu D; Yu J
    Oncotarget; 2017 Jul; 8(30):49702-49712. PubMed ID: 28591697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-VEGF and -PD-1 Combinations in Renal Cell Carcinoma: When Are Treatment Breaks Safe?
    Wells JC; Albiges L; Powles T
    Eur Urol; 2024 Jun; ():. PubMed ID: 38897866
    [No Abstract]   [Full Text] [Related]  

  • 4. PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.
    Alessi C; Scapulatempo Neto C; Viana CR; Vazquez VL
    Melanoma Res; 2017 Dec; 27(6):565-572. PubMed ID: 28984690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Leonard JP; Kolibaba KS; Reeves JA; Tulpule A; Flinn IW; Kolevska T; Robles R; Flowers CR; Collins R; DiBella NJ; Papish SW; Venugopal P; Horodner A; Tabatabai A; Hajdenberg J; Park J; Neuwirth R; Mulligan G; Suryanarayan K; Esseltine DL; de Vos S
    J Clin Oncol; 2017 Nov; 35(31):3538-3546. PubMed ID: 28862883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells.
    Gibbons Johnson RM; Dong H
    Front Immunol; 2017; 8():961. PubMed ID: 28848559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
    Roh J; Jeon Y; Lee AN; Lee SM; Kim Y; Sung CO; Park CJ; Hong JY; Yoon DH; Suh C; Huh J; Choi I; Park CS
    Oncotarget; 2017 Aug; 8(35):58122-58132. PubMed ID: 28938542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing L-asparaginase: efficacy and safety.
    Chan TSY; Li J; Loong F; Khong PL; Tse E; Kwong YL
    Ann Hematol; 2018 Jan; 97(1):193-196. PubMed ID: 28879531
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.
    Zheng M; Perry AM; Bierman P; Loberiza F; Nasr MR; Szwajcer D; Del Bigio MR; Smith LM; Zhang W; Greiner TC
    Neuropathology; 2017 Dec; 37(6):509-516. PubMed ID: 28856744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma.
    Kudo M
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.
    Meder L; Schuldt P; Thelen M; Schmitt A; Dietlein F; Klein S; Borchmann S; Wennhold K; Vlasic I; Oberbeck S; Riedel R; Florin A; Golfmann K; Schlößer HA; Odenthal M; Buettner R; Wolf J; Hallek M; Herling M; von Bergwelt-Baildon M; Reinhardt HC; Ullrich RT
    Cancer Res; 2018 Aug; 78(15):4270-4281. PubMed ID: 29776963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
    Li W; Wu J; Jia Q; Shi Y; Li F; Zhang L; Shi F; Wang X; Wu S
    BMC Cancer; 2024 May; 24(1):633. PubMed ID: 38783271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR, VEGF, and angiogenesis promote the development of lipoma in the oral cavity.
    Silva WRD; Pires HF; França GM; Freitas RA; Morais HGF; Galvão HC
    Braz Dent J; 2023; 34(2):113-121. PubMed ID: 37194849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PD-L1 antibody enhances curative effect of cryoablation
    Tan J; Liu T; Fan W; Wei J; Zhu B; Liu Y; Liu L; Zhang X; Chen S; Lin H; Zhang Y; Li J
    Acta Pharm Sin B; 2023 Feb; 13(2):632-647. PubMed ID: 36873191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma.
    Liu C; Liu L
    Front Genet; 2022; 13():1037716. PubMed ID: 36313435
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of
    Cui Y; Zhang P; Liang X; Xu J; Liu X; Wu Y; Zhang J; Wang W; Zhang F; Guo R
    Am J Cancer Res; 2022; 12(4):1766-1783. PubMed ID: 35530271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma.
    Tekiki N; Fujita M; Okui T; Kawai H; Oo MW; Kawazu T; Hisatomi M; Okada S; Takeshita Y; Barham M; Nagatsuka H; Yanagi Y; Asaumi JI
    Oncol Lett; 2021 Nov; 22(5):778. PubMed ID: 34594419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification ACTA2 and KDR as key proteins for prognosis of PD-1/PD-L1 blockade therapy in melanoma.
    Wang Y; Li Z; Zhang Z; Chen X
    Animal Model Exp Med; 2021 Jun; 4(2):138-150. PubMed ID: 34179721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma.
    Veldman J; Alsada ZND; van den Berg A; Plattel WJ; Diepstra A; Visser L
    Br J Haematol; 2021 May; 193(3):506-514. PubMed ID: 33620088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
    Nagpal P; Descalzi-Montoya DB; Lodhi N
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.